{"id":"https://openalex.org/W2005757381","doi":"https://doi.org/10.1046/j.1439-0507.2002.00724.x","title":"Clinical comparison of the efficacy and tolerability of once daily Canesten\u00ae with twice daily Nizoral\u00ae (clotrimazole 1% cream vs. ketoconazole 2% cream) during a 28\u2010day topical treatment of interdigital tinea pedis","display_name":"Clinical comparison of the efficacy and tolerability of once daily Canesten\u00ae with twice daily Nizoral\u00ae (clotrimazole 1% cream vs. ketoconazole 2% cream) during a 28\u2010day topical treatment of interdigital tinea pedis","publication_year":2002,"publication_date":"2002-04-01","ids":{"openalex":"https://openalex.org/W2005757381","doi":"https://doi.org/10.1046/j.1439-0507.2002.00724.x","mag":"2005757381","pmid":"https://pubmed.ncbi.nlm.nih.gov/12000508"},"language":"en","primary_location":{"id":"doi:10.1046/j.1439-0507.2002.00724.x","doi":"https://doi.org/10.1046/j.1439-0507.2002.00724.x","is_oa":false,"landing_page_url":"https://doi.org/10.1046/j.1439-0507.2002.00724.x","pdf_url":null,"source":{"id":"https://openalex.org/S80731565","display_name":"Mycoses","issn_l":"0027-5557","issn":["0027-5557","0933-7407","1439-0507"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Mycoses","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5041267543","display_name":"Sigrid Suschka","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210120689","display_name":"Universit\u00e4tsklinikum Aachen","ror":"https://ror.org/02gm5zw39","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210120689"]},{"id":"https://openalex.org/I887968799","display_name":"RWTH Aachen University","ror":"https://ror.org/04xfq0f34","country_code":"DE","type":"education","lineage":["https://openalex.org/I887968799"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Sigrid Suschka","raw_affiliation_strings":["Department of Dermatology, University Clinic of the RWTH, Aachen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Dermatology, University Clinic of the RWTH, Aachen, Germany","institution_ids":["https://openalex.org/I4210120689","https://openalex.org/I887968799"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036997483","display_name":"Bernward Fladung","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Bernward Fladung","raw_affiliation_strings":["Bayer AG, Consumer Care, Leverkusen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bayer AG, Consumer Care, Leverkusen, Germany","institution_ids":["https://openalex.org/I67348948"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5107838755","display_name":"Hans Friedrich Merk","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210120689","display_name":"Universit\u00e4tsklinikum Aachen","ror":"https://ror.org/02gm5zw39","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210120689"]},{"id":"https://openalex.org/I887968799","display_name":"RWTH Aachen University","ror":"https://ror.org/04xfq0f34","country_code":"DE","type":"education","lineage":["https://openalex.org/I887968799"]}],"countries":["DE"],"is_corresponding":true,"raw_author_name":"Hans F. Merk","raw_affiliation_strings":["Department of Dermatology, University Clinic of the RWTH Aachen, and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Dermatology, University Clinic of the RWTH Aachen, and","institution_ids":["https://openalex.org/I4210120689","https://openalex.org/I887968799"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5107838755"],"corresponding_institution_ids":["https://openalex.org/I4210120689","https://openalex.org/I887968799"],"apc_list":{"value":4780,"currency":"USD","value_usd":4780},"apc_paid":null,"fwci":1.7344,"has_fulltext":false,"cited_by_count":22,"citation_normalized_percentile":{"value":0.82542792,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"45","issue":"3-4","first_page":"91","last_page":"96"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11253","display_name":"Nail Diseases and Treatments","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11253","display_name":"Nail Diseases and Treatments","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10150","display_name":"Antifungal resistance and susceptibility","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10837","display_name":"Dermatology and Skin Diseases","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/interdigital-tinea","display_name":"interdigital tinea","score":0.9480000138282776},{"id":"https://openalex.org/keywords/clotrimazole","display_name":"clotrimazole","score":0.9480000138282776},{"id":"https://openalex.org/keywords/ketoconazole","display_name":"ketoconazole","score":1.0},{"id":"https://openalex.org/keywords/topical-antifungal-cream","display_name":"topical antifungal cream","score":0.9089999794960022},{"id":"https://openalex.org/keywords/once-daily-dosing","display_name":"once-daily dosing","score":0.9290000200271606},{"id":"https://openalex.org/keywords/twice-daily-dosing","display_name":"twice-daily dosing","score":0.9350000023841858},{"id":"https://openalex.org/keywords/treatment-efficacy","display_name":"treatment efficacy","score":0.703000009059906},{"id":"https://openalex.org/keywords/tolerability","display_name":"tolerability","score":0.9169999957084656},{"id":"https://openalex.org/keywords/pruritus","display_name":"pruritus","score":0.9539999961853027},{"id":"https://openalex.org/keywords/mycological-cure","display_name":"mycological cure","score":0.7419999837875366},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.5440000295639038}],"concepts":[{"id":"https://openalex.org/C2780628323","wikidata":"https://www.wikidata.org/wiki/Q413546","display_name":"Clotrimazole","level":3,"score":0.9774413704872131},{"id":"https://openalex.org/C2781064554","wikidata":"https://www.wikidata.org/wiki/Q407883","display_name":"Ketoconazole","level":3,"score":0.9577920436859131},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.8799769282341003},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8267358541488647},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5938926935195923},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.47384005784988403},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.36839017271995544},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.36098650097846985},{"id":"https://openalex.org/C2779548794","wikidata":"https://www.wikidata.org/wiki/Q578726","display_name":"Antifungal","level":2,"score":0.28691616654396057}],"mesh":[{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000935","descriptor_name":"Antifungal Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000935","descriptor_name":"Antifungal Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D003022","descriptor_name":"Clotrimazole","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D003022","descriptor_name":"Clotrimazole","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004821","descriptor_name":"Epidermophyton","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D004821","descriptor_name":"Epidermophyton","qualifier_ui":"Q000254","qualifier_name":"growth & development","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007654","descriptor_name":"Ketoconazole","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D007654","descriptor_name":"Ketoconazole","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009824","descriptor_name":"Ointments","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D009824","descriptor_name":"Ointments","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D014008","descriptor_name":"Tinea Pedis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D014008","descriptor_name":"Tinea Pedis","qualifier_ui":"Q000382","qualifier_name":"microbiology","is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1046/j.1439-0507.2002.00724.x","doi":"https://doi.org/10.1046/j.1439-0507.2002.00724.x","is_oa":false,"landing_page_url":"https://doi.org/10.1046/j.1439-0507.2002.00724.x","pdf_url":null,"source":{"id":"https://openalex.org/S80731565","display_name":"Mycoses","issn_l":"0027-5557","issn":["0027-5557","0933-7407","1439-0507"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Mycoses","raw_type":"journal-article"},{"id":"pmid:12000508","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12000508","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Mycoses","raw_type":"Clinical Trial"},{"id":"pmh:oai:publications.rwth-aachen.de:149715","doi":null,"is_oa":false,"landing_page_url":"https://publications.rwth-aachen.de/record/149715","pdf_url":null,"source":{"id":"https://openalex.org/S4306401362","display_name":"RWTH Publications (RWTH Aachen)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I887968799","host_organization_name":"RWTH Aachen University","host_organization_lineage":["https://openalex.org/I887968799"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Mycoses 45(3/4), 91-96 (2002). doi:10.1046/j.1439-0507.2002.00724.x","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.979200005531311,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Randomized Controlled Trial","id":"https://openalex.org/study-designs/randomized-controlled-trial"},{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":22,"referenced_works":["https://openalex.org/W132404472","https://openalex.org/W156514571","https://openalex.org/W1721308912","https://openalex.org/W1969546880","https://openalex.org/W1993290417","https://openalex.org/W2007548297","https://openalex.org/W2028757705","https://openalex.org/W2029586732","https://openalex.org/W2060580574","https://openalex.org/W2087808328","https://openalex.org/W2095051720","https://openalex.org/W2114259209","https://openalex.org/W2118448039","https://openalex.org/W2140313246","https://openalex.org/W2169001753","https://openalex.org/W2171477269","https://openalex.org/W2397640310","https://openalex.org/W2993007582","https://openalex.org/W4230653127","https://openalex.org/W4230878297","https://openalex.org/W4232123096","https://openalex.org/W6637511141"],"related_works":["https://openalex.org/W2005588404","https://openalex.org/W1956528570","https://openalex.org/W2140313246","https://openalex.org/W2118448039","https://openalex.org/W2028757705","https://openalex.org/W2981949413","https://openalex.org/W156514571","https://openalex.org/W2127105768","https://openalex.org/W103565584","https://openalex.org/W2415665331"],"abstract_inverted_index":{"Summary.":[0],"The":[1,49,87,129],"effects":[2],"of":[3,27,57,81,100,119,127,131,135,173,233,247,266,282],"two":[4,147,278],"topical":[5],"cream":[6],"formulations":[7],"containing":[8],"clotrimazole":[9,43,181,241,251],"1%":[10,327],"and":[11,94,111,138,149,170,191,213,242,249,270],"ketoconazole":[12,184,243,257],"2%,":[13],"respectively,":[14],"were":[15,178],"clinically":[16],"compared":[17],"in":[18,31,96,105,112,154,338,374,460],"a":[19,24,91,122,230],"double\u2010blind,":[20],"randomized":[21],"manner":[22],"for":[23,76,186],"28\u2010day":[25],"therapy":[26,232],"interdigital":[28],"tinea":[29,234],"pedis":[30,235,311,319,553],"106":[32,314],"treated":[33],"patients.":[34,86,205],"Ketoconazole":[35],"was":[36,44,67,430,502],"to":[37,159,167],"be":[38,237,275],"used":[39],"twice":[40],"daily":[41],"whereas":[42],"administered":[45],"only":[46,222],"once":[47],"daily.":[48],"primary":[50],"response":[51,89],"criterion":[52],"defined":[53],"as":[54,200,210,255],"the":[55,77,101,132,146,168,204,262,267],"number":[56],"patients":[58,102],"with":[59,69,221,239,258],"cure":[60,273],"or":[61],"improvement":[62,171],"after":[63,103,109,116,280],"28":[64,245,370,420,555],"treatment":[65,248],"days":[66,118,246],"comparable":[68],"62.0%":[70],"vs.":[71,74,84,98,107,114,161,189,194,217,224,300,379,382,394,408,417,425,468,495,500,529,536],"64.0%":[72],"(clotrimazole":[73],"ketoconazole)":[75],"full":[78],"analysis":[79],"set":[80],"100":[82,392],"(50":[83,393],"50)":[85,395],"mycological":[88],"revealed":[90],"negative":[92,402],"culture":[93],"microscopy":[95],"53.1%":[97,407],"52.1%":[99,409],"14,":[104],"76.0%":[106,416],"79.2%":[108,418],"28,":[110],"83.7%":[113],"76.9%":[115,426],"56":[117,428,472],"observation,":[120],"indicating":[121],"possibly":[123],"better":[124,176],"long\u2010term":[125],"efficacy":[126],"clotrimazole.":[128],"development":[130],"overall":[133],"score":[134],"tinea\u2010related":[136],"signs":[137],"symptoms":[139,265],"did":[140],"not":[141],"show":[142],"relevant":[143],"differences":[144],"between":[145],"drugs":[148],"continuously":[150],"decreased":[151],"from":[152],"11\u00b15":[153,459],"both":[155,197,207,240],"groups":[156],"at":[157,163],"baseline":[158],"2\u00b12":[160,467],"2\u00b11":[162,469],"day":[164],"56.":[165],"As":[166],"remission":[169],"rates":[172],"single":[174],"symptoms,":[175],"results":[177],"obtained":[179],"under":[180,183],"than":[182],"particularly":[185],"pruritus":[187],"(97.8":[188],"89.6%)":[190,496],"burning/stinging":[192],"(97.5":[193],"89.4%)":[195],"which":[196],"are":[198],"perceived":[199],"most":[201,263],"bothersome":[202],"by":[203],"Furthermore,":[206],"substances":[208],"appeared":[209],"comparably":[211],"safe":[212],"well":[214],"tolerable":[215],"(8":[216],"7":[218,530],"adverse":[219],"events":[220],"1":[223,535],"3":[225,537],"drug":[226],"related).":[227],"In":[228],"conclusion,":[229],"successful":[231],"can":[236],"achieved":[238],"within":[244],"once\u2010daily":[250],"is":[252],"equally":[253],"effective":[254],"twice\u2010daily":[256],"favourable":[259],"influences":[260],"on":[261],"irritating":[264],"disease.":[268],"Mycological":[269],"reliable":[271],"clinical":[272],"cannot":[274],"observed":[276],"during":[277],"weeks":[279],"start":[281],"treatment.":[283],"Klinischer":[284],"Vergleich":[285],"der":[286,308,363,410,479,551,586,588,602],"Wirksamkeit":[287],"und":[288,328,341,404,422,455,477,497,522,595],"Vertra\u00a8glichkeit":[289],"von":[290,391,436,443,458,504],"Canesten\u00ae":[291],"1\u2010mal":[292],"tgl.":[293,297],"mit":[294,316,365,377,538,558,562,582],"Nizoral\u00ae":[295],"2\u2010mal":[296],"(1%":[298],"Clotrimazol\u2010Salbe":[299],"2%":[301],"Ketoconazol\u2010Salbe)":[302],"bei":[303,406,415,423,526,585],"einer":[304,332],"28\u2010ta\u00a8gigen":[305,333],"topischen":[306],"Behandlung":[307,334,550],"interdigitalen":[309],"Tinea":[310,318,444,552],"Zusammenfassung.":[312],"Bei":[313],"Patienten":[315,364,411,506],"interdigitaler":[317],"wurden":[320],"die":[321,361,475],"Effekte":[322],"zweier":[323],"topischer":[324],"Cre`mes":[325,454,516],"(Clotrimazol":[326,381],"Ketoconazol":[329,345,490,563,578],"2%)":[330],"wa\u00a8hrend":[331,601],"des":[335,356,387,441],"Fu\u00dfpilzes":[336],"klinisch":[337],"einem":[339],"doppelblinden":[340],"randomisierten":[342],"Ansatz":[343],"verglichen.":[344],"wurde":[346],"dabei":[347],"zweimal,":[348],"Clotrimazol":[349,437,487,559,571],"lediglich":[350],"einmal":[351,572],"ta\u00a8glich":[352,573,580],"verabreicht.":[353],"Das":[354],"Ergebnis":[355],"prima\u00a8ren":[357],"Response\u2010Kriteriums,":[358],"definiert":[359],"als":[360,488,508,520,560,574],"Anzahl":[362],"Heilung":[366,599],"oder":[367],"Besserung":[368],"nach":[369,412,419,427],"Tagen,":[371,414],"war":[372],"vergleichbar":[373],"beiden":[375,453,461,604],"Behandlungsgruppen":[376],"62%":[378],"64%":[380],"Ketoconazol)":[383],"fu\u00a8r":[384],"das":[385],"Auswertungskollektiv":[386],"\u2018Full":[388],"Analysis":[389],"Set\u2019":[390],"Fa\u00a8llen.":[396],"Die":[397],"mykologische":[398,594],"Response":[399],"zeigte":[400],"eine":[401,549],"Kultur":[403],"Mikroskopie":[405],"14":[413],"Tagen":[421],"83.7":[424],"Beobachtungstagen,":[429],"auf":[431,466],"einen":[432],"mo\u00a8glicherweise":[433],"besseren":[434],"Langzeiteffekt":[435],"hindeutet.":[438],"Der":[439],"Verlauf":[440],"Gesamtscores":[442],"Pedis\u2010typischen":[445],"Symptomen":[446],"ergab":[447],"keine":[448],"relevanten":[449],"Unterschiede":[450],"zwischen":[451],"den":[452,505],"nahm":[456],"kontinuierlich":[457],"Gruppen":[462],"an":[463,470],"Tag":[464,471],"0":[465],"ab.":[473],"Fu\u00a8r":[474],"Remissions\u2010":[476],"Verbesserungsraten":[478],"einzelnen":[480],"Symptome":[481],"zeigten":[482],"sich":[483,570],"bessere":[484],"Ergebnisse":[485],"unter":[486,489],"besonders":[491],"bezu\u00a8glich":[492],"Juckreiz":[493],"(97.8%":[494],"Brennen/Stechen":[498],"(97.5%":[499],"89.4%),":[501],"beides":[503],"auch":[507,561],"am":[509,589],"meisten":[510,590],"beeintra\u00a8chtigend":[511],"empfunden":[512],"wird.":[513],"Beide":[514],"verwendeten":[515],"ko\u00a8nnen":[517],"daru\u00a8ber":[518],"hinaus":[519],"sicher":[521],"gut":[523],"vertra\u00a8glich":[524],"gelten":[525],"insgesamt":[527],"8":[528],"unerwu\u00a8nschten":[531],"Ereignissen,":[532],"davon":[533],"nur":[534],"vermuteter":[539],"Beziehung":[540],"zur":[541],"verabreichten":[542],"Cre`me.":[543],"Es":[544],"wird":[545],"also":[546],"deutlich,":[547],"da\u00df":[548],"u\u00a8ber":[554],"Tage":[556],"sowohl":[557],"erfolgreich":[564],"durchgefu\u00a8hrt":[565],"werden":[566],"kann.":[567],"Dabei":[568],"stellt":[569],"gleichwertig":[575],"wirksam":[576],"zu":[577,607],"zweimal":[579],"dar,":[581],"zusa\u00a8tzlichen":[583],"Vorteilen":[584],"Verbesserung":[587],"beeintra\u00a8chtigenden":[591],"Krankheitssymptome.":[592],"Eine":[593],"gleichzeitig":[596],"zufriedenstellende":[597],"klinische":[598],"ist":[600],"ersten":[603],"Behandlungswochen":[605],"nicht":[606],"beobachten.":[608]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":3}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}